Literature DB >> 8925763

[Endoscopic repositioning of the upside-down stomach and its fixation by percutaneous endoscopic gastrostomy].

R Januschowski1.   

Abstract

HISTORY: A 77-year-old woman developed progressively increasing weakness, vertigo, dyspnoea, cardiac arrhythmias, left-sided chest pain, dyspepsia, dysphagia and weight loss. 11 years before admission she had a right mastectomy and 5 years later a left mastectomy, both for carcinoma.
FINDINGS: She had an iron deficiency anaemia (haemoglobin 6.8 g/dl, ferritin level 9 mg/dl, mean corpuscular volume 64.3 fl). Neoplasm was excluded by extensive radiological and endoscopic examination, which however demonstrated upside-down stomach due to a large paraesophageal hernia. TREATMENT AND COURSE: Percutaneous gastroscopic gastrostomy was performed to reposition and fixate the stomach. Using two gastroscopes the stomach was replaced into the abdomen and fixed with three gastrostomies. The gastrostomy tubes were removed 15 days later. One year after the operation the patient was symptom-free and the stomach remained well fixed. A small residual hernia was still demonstrable radiologically.
CONCLUSION: This case suggests that percutaneous endoscopic gastrostomy is a satisfactory procedure for the repair of an upside-down stomach.

Entities:  

Mesh:

Year:  1996        PMID: 8925763     DOI: 10.1055/s-2008-1043137

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

1.  Gangrenous stomach in mesentroaxial volvulus.

Authors:  Mitha Lal Meena; R K Jenav; R Mandia
Journal:  Indian J Surg       Date:  2010-12-22       Impact factor: 0.656

2.  Percutaneous endoscopic gastrostomy in a patient with a large hiatal hernia using laparoscopy.

Authors:  E S Xenos
Journal:  JSLS       Date:  2000 Jul-Sep       Impact factor: 2.172

3.  Management of acute upside-down stomach.

Authors:  Tobias S Schiergens; Michael N Thomas; Thomas P Hüttl; Wolfgang E Thasler
Journal:  BMC Surg       Date:  2013-11-15       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.